Search the Newsreel

NexGel, Inc Revenue Breakdown – BOATS:NXGLW

NexGel, Inc (NXGLW) reported a total revenue of $11.42 million USD last year. The majority of this revenue, $8.61 million USD, was generated by its NexGel segment, an increase from $6.63 million USD in the prior year. The United States was the primary contributor …

NexGel Updates CEO Employment Terms and Incentive Plan

NexGel Inc. announced updates to President and CEO Adam Levy's employment terms, including a new annual base salary of $375,000, a 2026 bonus structure tied to performance and EBITDA targets, and a grant of options for up to 160,000 shares. The agreement, which replaces …

Nexgel Inc (NXGL) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Nexgel Inc (NXGL), highlighting its beta value of 0.74, indicating lower volatility compared to the S&P 500. The company's current risk assessment score is 2.23, placing it 130th out of 155 in the Pharmaceuticals industry. The analysis …

NXGL|Nexgel Inc|Price:0.415|Chg%:-0.029

This article provides a comprehensive stock analysis of Nexgel Inc (NXGL) from TradingKey, highlighting its stable fundamentals, high growth potential, and fair valuation within the Pharmaceuticals industry. The company's stock score details its financial health, institutional confidence, and an analyst rating of "Buy" with …

Nexgel Inc (NXGL) Institutional Confidence

Nexgel Inc (NXGL) has an institutional confidence score of 3.00, placing it 92nd out of 155 in the Pharmaceuticals industry. Institutional shareholding has increased by 118.57% quarter-over-quarter, now standing at 14.76%. James Simons is the largest institutional shareholder, holding 0.60% of outstanding shares.

Form 4 Nexgel Inc For: 29 July By Investing.com

This article reports on a Form 4 filing for Nexgel Inc. related to activity on July 29th. It is a brief financial news item from Investing.com, typical of filings news. The article provides the company name and filing date, without further details in the …

Nexgel Inc (NXGL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Nexgel Inc (NXGL), noting its current valuation score of 7.43, which ranks 123 out of 155 in the Pharmaceuticals industry. It highlights that the company's current P/E ratio is -1.10, indicating a decrease of 7.40% from its …

Adam Levy signs new employment agreement as NexGel CEO with revised pay and equity

NexGel (NXGL) has executed a new Executive Employment Agreement with its President and CEO, Adam Levy, effective July 23, 2026. This agreement outlines his salary, bonus potential, equity grants, and severance terms. The compensation package includes a base salary of $375,000 and options for …

NexGel, Inc Revenue Breakdown – NASDAQ:NXGL

NexGel, Inc (NASDAQ: NXGL) generated $11.42 million USD in revenue last year, with its NexGel segment contributing the most at $8.61 million USD. The United States was the primary source of this revenue, accounting for the entire $11.42 million USD. This indicates a significant …

Nexgel Inc (NXGL) Balance Sheet

This article provides a detailed balance sheet for Nexgel Inc (NXGL), offering quarterly and annual financial data. It allows users to analyze the company's financial health, liquidity, leverage, and return on equity through various metrics. The report includes key figures such as cash and …

Nexgel Inc (NXGL) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Nexgel Inc (NXGL), covering operating, investing, and financing activities. It presents financial figures with year-over-year percentage changes and defines key cash flow terms. The data helps evaluate the company's financial health, stability, …

Nexgel Inc (NXGL) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Nexgel Inc. (NXGL) focusing on its dividend and stock split history. It states that no dividend data is available for the company, indicating that Nexgel Inc. has not distributed dividends in the past five years. The article also …

TradingKey

This page provides the quarterly and annual income statements for Nexgel Inc (NXGL), detailing financial performance metrics such as total revenue, cost of revenue, operating expenses, and net income. It also includes key financial figures for recent periods and offers FAQs on how to …

Nexgel Inc (NXGL) Income Statement

NXGL|Nexgel Inc|Price:0.439|Chg%:+0.009

Nexgel Inc (NXGL) is trading at $0.439, up 2.09%, with a market capitalization of $3.57 million. The company, which specializes in hydrogel products for healthcare and consumer applications, has strong fundamentals, high growth potential, and institutional buying activity, although its stock performance has been …

Price to sales forward of NexGel, Inc – NASDAQ:NXGL

This page displays the "Price to sales forward" financial metric for NexGel, Inc (NASDAQ:NXGL) on TradingView. It indicates that the market was closed at the time of viewing with no trades. The article is primarily a financial data display page with navigational elements and …

Enterprise value to revenue forward of NexGel, Inc – NASDAQ:NXGL

This article provides financial information for NexGel, Inc (NASDAQ: NXGL) from TradingView, specifically focusing on its enterprise value to revenue forward. It presents a table with the period, value, change, and percentage change for this metric. The page also includes general market data and …

NXGL stock holds focus as NexGel files a quarter update

NexGel, Inc. (NASDAQ: NXGL) reported Q1 2026 revenue of $1.3 million and a net loss of $2.3 million. The company ended the quarter with $5.9 million in cash, highlighting the ongoing effort to bridge the gap between commercial scale and profitability. The hydrogel business …

NexGel(NXGL) Stock Options Chain | Quotes & News

This article provides limited content for NexGel (NXGL). It appears to be a stub or placeholder page for the company's stock options chain, quotes, and news.